Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy

BACKGROUND: (161)Tb is an interesting radionuclide for cancer treatment, showing similar decay characteristics and chemical behavior to clinically-employed (177)Lu. The therapeutic effect of (161)Tb, however, may be enhanced due to the co-emission of a larger number of conversion and Auger electrons...

Descripción completa

Detalles Bibliográficos
Autores principales: Gracheva, Nadezda, Müller, Cristina, Talip, Zeynep, Heinitz, Stephan, Köster, Ulli, Zeevaart, Jan Rijn, Vögele, Alexander, Schibli, Roger, van der Meulen, Nicholas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620226/
https://www.ncbi.nlm.nih.gov/pubmed/31659528
http://dx.doi.org/10.1186/s41181-019-0063-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620226/
https://www.ncbi.nlm.nih.gov/pubmed/31659528
http://dx.doi.org/10.1186/s41181-019-0063-6

Ejemplares similares